Cargando…
IgA Nephropathy that Developed as an Immune-related Adverse Event of Pembrolizumab Complicated with Interstitial Nephritis
A 70-year-old man received pembrolizumab as a second-line treatment for squamous cell lung cancer of the lower right lobe. After three courses, proteinuria and hematuria were observed, which worsened after seven courses. He was diagnosed with a combination of IgA nephropathy and active interstitial...
Autores principales: | Mitarai, Yuki, Nakashima, Kazuhisa, Fukunaga, Shohei, Ishikawa, Noriyoshi, Ito, Takafumi, Tsubata, Yukari, Isobe, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334229/ https://www.ncbi.nlm.nih.gov/pubmed/34840226 http://dx.doi.org/10.2169/internalmedicine.7115-21 |
Ejemplares similares
-
Diagnosis and treatment of IgA nephropathy and IgA vasculitis nephritis in Chinese children
por: Zhong, Xuhui, et al.
Publicado: (2022) -
Comparative proteomic analysis of glomerular proteins in IgA nephropathy and IgA vasculitis with nephritis
por: Kaga, Hajime, et al.
Publicado: (2023) -
Safety Evaluation of COVID-19 Vaccine in Patients With IgA Nephropathy or IgA Vasculitis Nephritis
por: Zan, Jincan, et al.
Publicado: (2022) -
Comparative study on clinicopathological features and prognosis of IgA vasculitis nephritis and IgA nephropathy in children
por: Lv, Yan, et al.
Publicado: (2023) -
Zonulin, as a marker of intestinal permeability, is elevated in IgA nephropathy and IgA vasculitis with nephritis
por: Li, Qianqian, et al.
Publicado: (2022)